InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,279.60
(
0.34%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.26
(
0.93%
)
Bitcoin
61,413.17
(
0.99%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

$$$eeker

Send PM Follow Ignore
Followers 29
Posts 2503
Boards Moderated 0
Alias Born 04/09/2010

$$$eeker

Re: None

Monday, 03/17/2014 7:31:18 PM

Monday, March 17, 2014 7:31:18 PM

Post# of 97239
Gilead's breakthrough hepatitis C drug is too expensive, medical experts say
By Matthew Perrone

Associated Press

POSTED: 03/11/2014 09:38:21 AM PDT14 COMMENTS| UPDATED: 6 DAYS AGO

WASHINGTON -- An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences.

A panel of California medical experts voted Monday that Gilead's Sovaldi represents a "low value" treatment, considering its cost compared with older drugs for the blood-borne virus.



http://bit.ly/1kgBzb3
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up